Related Experiment Video

Updated: Jun 26, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

[Risk of fungal disease during systemic diseases]

David Lebeaux1, Fanny Lanternier, Agnès Lefort

  • 1Service des Maladies Infectieuses et Tropicales, Université Paris Descartes, Hôpital Necker Enfants Malades, Centre d'Infectiologie Necker-Pasteur, F-75743 Paris Cedex 15, France.

Presse Medicale (Paris, France : 1983)
|December 30, 2008
PubMed

Insights

Invasive fungal diseases cause high mortality and are often underdiagnosed in systemic diseases. Early diagnosis and preventive strategies are crucial for improving patient outcomes.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Critical Care Medicine

Context:

  • Invasive fungal diseases (IFDs) present a significant challenge in systemic illness, often overshadowed by bacterial infections.
  • Despite high mortality, IFDs are frequently underdiagnosed due to non-specific clinical signs and limited diagnostic evaluations.
  • Current diagnostic methods, including non-invasive tools and histology, have limitations in systemic disease contexts.

Purpose:

  • To highlight the diagnostic challenges associated with invasive fungal diseases in patients with systemic illnesses.
  • To emphasize the underdiagnosis of IFDs and the need for improved diagnostic strategies.
  • To underscore the necessity of evaluating preventive measures for IFDs in immunocompromised patient populations.

Summary:

  • Invasive fungal diseases are rare but deadly complications in systemic diseases, often missed by clinicians.
  • Diagnostic difficulties arise from overlapping symptoms with other systemic conditions and the infrequent use of invasive procedures like histology.
  • While curative treatments exist, preventive strategies for IFDs in systemic disease patients require further research and evaluation.

Impact:

  • Improved diagnostic accuracy for invasive fungal diseases can lead to timely treatment and reduced mortality.
  • Enhanced understanding of IFD presentation in systemic diseases will aid clinical recognition and management.
  • Development of effective preventive strategies will significantly improve survival rates for patients at risk.

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...